GigaGen’s development of the world’s first synthetic immune system was covered recently in the Biospace.com story Bay Area’s GigaGen Develops Synthetic Immune System to Harness Antibodies.

 

According to the article, “The development of therapeutics that harness the body’s immune system has exploded in popularity among biotech companies with many investing heavily in research and development. Now, GigaGen, a biotech startup with its roots at Stanford University, has developed one of the world’s first synthetic immune system that executives believe will allow the company to treat multiple illnesses and develop drugs at a much faster pace.”